Rasouli-Nia A - Search Results

1

Cell Proliferation, Viability, Differentiation, and Apoptosis of Iron Oxide Labeled Stem Cells Transfected with Lipofectamine Assessed by MRI.

Jalli R, Mehrabani D, Zare S, Saeedi Moghadam M, Jamhiri I, Manafi N, Mehrabani G, Ghabanchi J, Razeghian Jahromi I, Rasouli-Nia A, Karimi-Busheri F. Jalli R, et al. Among authors: rasouli nia a. J Clin Med. 2023 Mar 20;12(6):2395. doi: 10.3390/jcm12062395. J Clin Med. 2023. PMID: 36983399 Free PMC article.

2

Integration, Networking, and Global Biobanking in the Age of New Biology.

Karimi-Busheri F, Rasouli-Nia A. Karimi-Busheri F, et al. Among authors: rasouli nia a. Adv Exp Med Biol. 2015;864:1-9. doi: 10.1007/978-3-319-20579-3_1. Adv Exp Med Biol. 2015. PMID: 26420609 Review.

3

Karimi-Busheri F, Rasouli-Nia A, Weinfeld M. Karimi-Busheri F, et al. Among authors: rasouli nia a. Adv Exp Med Biol. 2016;951:1-12. doi: 10.1007/978-3-319-45457-3_1. Adv Exp Med Biol. 2016. PMID: 27837550 Review.

4

Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents.

Rasouli-Nia A, Karimi-Busheri F, Weinfeld M. Rasouli-Nia A, et al. Proc Natl Acad Sci U S A. 2004 May 4;101(18):6905-10. doi: 10.1073/pnas.0400099101. Epub 2004 Apr 20. Proc Natl Acad Sci U S A. 2004. PMID: 15100409 Free PMC article.

5

Senescence evasion by MCF-7 human breast tumor-initiating cells.

Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M. Karimi-Busheri F, et al. Among authors: rasouli nia a. Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2. Breast Cancer Res. 2010. PMID: 20525204 Free PMC article.

6

Human polynucleotide kinase participates in repair of DNA double-strand breaks by nonhomologous end joining but not homologous recombination.

Karimi-Busheri F, Rasouli-Nia A, Allalunis-Turner J, Weinfeld M. Karimi-Busheri F, et al. Among authors: rasouli nia a. Cancer Res. 2007 Jul 15;67(14):6619-25. doi: 10.1158/0008-5472.CAN-07-0480. Cancer Res. 2007. PMID: 17638872

7

CD24+/CD38- as new prognostic marker for non-small cell lung cancer.

Karimi-Busheri F, Rasouli-Nia A, Zadorozhny V, Fakhrai H. Karimi-Busheri F, et al. Among authors: rasouli nia a. Multidiscip Respir Med. 2013 Oct 5;8(1):65. doi: 10.1186/2049-6958-8-65. Multidiscip Respir Med. 2013. PMID: 24094028 Free PMC article.

8

Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors.

Bernstein NK, Karimi-Busheri F, Rasouli-Nia A, Mani R, Dianov G, Glover JN, Weinfeld M. Bernstein NK, et al. Among authors: rasouli nia a. Anticancer Agents Med Chem. 2008 May;8(4):358-67. doi: 10.2174/187152008784220311. Anticancer Agents Med Chem. 2008. PMID: 18473721 Free PMC article. Review.

9

Identification of a small molecule inhibitor of the human DNA repair enzyme polynucleotide kinase/phosphatase.

Freschauf GK, Karimi-Busheri F, Ulaczyk-Lesanko A, Mereniuk TR, Ahrens A, Koshy JM, Rasouli-Nia A, Pasarj P, Holmes CF, Rininsland F, Hall DG, Weinfeld M. Freschauf GK, et al. Among authors: rasouli nia a. Cancer Res. 2009 Oct 1;69(19):7739-46. doi: 10.1158/0008-5472.CAN-09-1805. Epub 2009 Sep 22. Cancer Res. 2009. PMID: 19773431

10

Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2.

Lee JH, Jung C, Javadian-Elyaderani P, Schweyer S, Schütte D, Shoukier M, Karimi-Busheri F, Weinfeld M, Rasouli-Nia A, Hengstler JG, Mantilla A, Soleimanpour-Lichaei HR, Engel W, Robson CN, Nayernia K. Lee JH, et al. Among authors: rasouli nia a. Cancer Res. 2010 Jun 1;70(11):4569-79. doi: 10.1158/0008-5472.CAN-09-2670. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page